Found 5 matching trials
Study With SCB-313 (Recombinant Human TRAIL-Trimer Fusion Protein) for Treatment of Malignant Pleural Effusions
PHASE1The purpose of this study is to evaluate the safety, tolerability, prelimin...
Location
Liverpool Hospital
A Phase I Study Evaluating SCB-313 for the Treatment of Subjects With Peritoneal Carcinomatosis
PHASE1To evaluate the safety and tolerability of SCB-313 in patients with periton...
Location
Beijing Shijitan Hospital Capital Medical University
A Phase I Study Evaluating SCB-313(Recombinant Human TRAIL-Trimer Fusion Protein) for the Treatment of Malignant Pleural Effusion
PHASE1To evaluate the safety and tolerability of single dose of SCB-313 by intrap...
Location
West China Hospitial, Sichuan University
Study With SCB-313 (Recombinant Human TRAIL-Trimer Fusion Protein) for Treatment of Peritoneal Malignancies
PHASE1The purpose of this study is to evaluate the safety, tolerability, immunoge...
Location
Liverpool Hospital
Study With SCB-313 (Recombinant Human TRAIL-Trimer Fusion Protein) for Treatment of Malignant Ascites
PHASE11. The safety and tolerability of single-dose of SCB-313 will be evaluated ...
Location
Shanghai East Hospital